HIV Wasting

• Treatment Guidelines for HIV-Associated Wasting  
  By Bruce Polsky, MD; Donald Kotler, MD; and Corklin Steinhart, MD, PhD

• Food and Nutrition Insecurity Complicate HIV Care in Developing Countries  
  By Ellen Engelson, EdD

• HIV Wasting (Animated: 42 page/slide presentation) (45 Slide Presentation)

Articles on Wasting

Increase in Limb Fat after Stopping Nucleoside Analogue Therapy Is Not Associated with Decreased Visceral Fat and Has Different Risk Factors - 12/09/05

Risk Factors for Lipoatrophy - 12/09/05

Supplementation with Creatine Does Not Improve the Benefits from Resistance Exercise Training in HIV Patients - 12/09/05

Body Fat Changes in Children with HIV Infection - 12/09/05

HIV Patients with Lipoatrophy Have High Levels of Anxiety and Depression and Low Self Esteem with Poorer Quality of Life - 12/09/05

Anthropometry and Bioimpedance Are Inexpensive Office-based Assessments of Body Shape Changes in Patients on HAART - 12/09/05

Is Fat Mass Ratio an Objective Tool for Diagnosis of HIV Lipodystrophy Syndrome Diagnosis? - 12/09/05

Patient Perspective Is Essential in Medical Decision-making about Lipodystrophy - 12/09/05

Body Shape Changes 1 and 2 Years after Switch to Tenofovir from Stavudine - 12/09/05

New Study in Patients with AIDS Wasting Shows Superiority of Exercise over Oxandrolone Use in Improving Strength, with Lower Risk of Adverse Effects and at a Lower Cost - 3/25/05

Serono Completes Enrollment for Phase III Trial of Serostim for HIV-associated Fat Redistribution - 1/26/05

Modest Benefit of Nandrolone Decanoate for HIV/AIDS Wasting - 11/19/04

96-Week Lipids and Anthropometrics in Patients Receiving Initial Therapy with Abacavir + Lamivudine Combined with Efavirenz, Amprenavir/Ritonavir or Stavudine: The Class Study  - 08/09/04

Diarrhea and Reduced Levels of Antiretroviral Drugs: Improvement with Glutamine or Alanyl-glutamine - 7/07/07

Human Growth Hormone (rhGH) Improves Lean Body Mass, Physical Performance, and Quality of Life in HIV Patients on HAART with HIV-related Weight Loss or Wasting 03/24/04

Enhanced Saquinavir (Invirase) Exposure in HIV Patients with Diarrhea and/or Wasting Syndrome -3/10/04

Oxymethalone Is Effective for HIV Wasting 02/18/04

Enhanced Saquinavir Exposure in HIV Patients with Diarrhea and/or Wasting Syndrome - 02/04/04

Administration of V-1 Immunitor, an oral Therapeutic Vaccine, Increases Body Weight and Improves Quality of Life in AIDS Patients - 01/12/04

Facial Implants for HIV and HAART-related Lipoatrophy: An Interview with Dr. Gottfried Lemperle - 11/19/03

FDA Grants Full Approval to Serono's Serostim (recombinant growth hormone) for Treatment of AIDS-related Wasting - 09/03/03

AIDS Wasting Syndrome Is Declining in US - 07/25/03

AIDS Wasting Syndrome: Trends, Influence on Opportunistic Infections, and Survival
- 06/16/03

CA Officials Will Tighten Controls on Serostim (human growth hormone) Due to High Costs of Unauthorized Use of the Drug - 04/09/03

Anabolic Steroid Oxymetholone Reduces Wasting Among HIV Patients on HAART - 04/03/03